Jazz Pharmaceuticals plc

Status: Publicly traded

Direct answer

Jazz Pharmaceuticals plc is publicly traded on NASDAQ under the ticker JAZZ.

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the...

Can you invest in Jazz Pharmaceuticals plc?

Yes. Jazz Pharmaceuticals plc is publicly traded on NASDAQ under the ticker JAZZ.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Jazz Pharmaceuticals plc

Detailed equity research is provided by MarketSnap.